Suprascapular Nerve PRF for Central Sensitization and Neuropathic Pain

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 27, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

February 28, 2026

Conditions
Shoulder Pain
Interventions
PROCEDURE

pulsed radiofrequency

All patients will be monitored with electrocardiography, non-invasive blood pressure, and peripheral oxygen saturation, and peripheral intravenous vascular access will be performed before the procedure. Patients will be placed in a sitting position. The physician will stand behind the patient for the posterior approach. The skin area to be injected will be prepared and covered in a sterile manner using a povidone-iodine-based solution. The operator will use ultrasound (a TOSHIBA Aplio 500 Ultrasound) guidance to perform suprascapular nerve radiofrequency. The suprascapular notch will be visualized. A twenty-two gauge, 10 cm long, and 10 mm active-tipped radiofrequency cannula will be introduced to the suprascapular notch. Motor stimulation will be performed at 2 Hz at a setting of 1 V, and sensory stimulation will be performed at 50 Hz at a setting of 0.5 V. After the needle tip confirmation, pulsed radiofrequency will be applied to the suprascapular nerve for 360 seconds.

Trial Locations (1)

Unknown

Ankara Bilkent City Hospital, Ankara

All Listed Sponsors
lead

Gülçin Babaoğlu

OTHER

NCT06857409 - Suprascapular Nerve PRF for Central Sensitization and Neuropathic Pain | Biotech Hunter | Biotech Hunter